BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35970393)

  • 1. Lysine demethylase KDM1A promotes cell growth via FKBP8-BCL2 axis in hepatocellular carcinoma.
    Lv S; Zhao X; Zhang E; Yan Y; Ma X; Li N; Zou Q; Sun L; Song T
    J Biol Chem; 2022 Sep; 298(9):102374. PubMed ID: 35970393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma.
    Huang M; Chen C; Geng J; Han D; Wang T; Xie T; Wang L; Wang Y; Wang C; Lei Z; Chu X
    Cancer Lett; 2017 Jul; 398():12-21. PubMed ID: 28377178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y; Cao K
    J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.
    Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF
    Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
    Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
    J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma.
    Gai X; Tu K; Li C; Lu Z; Roberts LR; Zheng X
    Cell Death Dis; 2015 Apr; 6(4):e1712. PubMed ID: 25855960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.
    Lee J; Kim JS; Cho HI; Jo SR; Jang YK
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.
    Brenner C; Luciani J; Bizet M; Ndlovu M; Josseaux E; Dedeurwaerder S; Calonne E; Putmans P; Cartron PF; Defrance M; Fuks F; Deplus R
    Oncotarget; 2016 Sep; 7(37):58939-58952. PubMed ID: 27449289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.
    Jiang Q; Stachelscheid J; Bloehdorn J; Pacholewska A; Aszyk C; Grotenhuijs F; Müller T; Onder O; Wagle P; Herling CD; Kleppe M; Wang Z; Coombes KR; Robrecht S; Dalvi PS; Plosnita B; Mayer P; Abruzzo LV; Altmüller J; Gathof B; Persigehl T; Fischer K; Jebaraj B; Rienhoff HY; Ecker R; Zhao Y; Bruns CJ; Stilgenbauer S; Elenitoba-Johnson K; Hallek M; Schweiger MR; Odenthal M; Vasyutina E; Herling M
    Blood; 2023 Jul; 142(1):44-61. PubMed ID: 37023372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
    Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
    Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline Lysine-Specific Demethylase 1 (
    Wei X; Calvo-Vidal MN; Chen S; Wu G; Revuelta MV; Sun J; Zhang J; Walsh MF; Nichols KE; Joseph V; Snyder C; Vachon CM; McKay JD; Wang SP; Jayabalan DS; Jacobs LM; Becirovic D; Waller RG; Artomov M; Viale A; Patel J; Phillip J; Chen-Kiang S; Curtin K; Salama M; Atanackovic D; Niesvizky R; Landgren O; Slager SL; Godley LA; Churpek J; Garber JE; Anderson KC; Daly MJ; Roeder RG; Dumontet C; Lynch HT; Mullighan CG; Camp NJ; Offit K; Klein RJ; Yu H; Cerchietti L; Lipkin SM
    Cancer Res; 2018 May; 78(10):2747-2759. PubMed ID: 29559475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
    Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
    J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.
    Li X; Zhang K; Hu Y; Luo N
    Am J Pathol; 2023 Apr; 193(4):442-455. PubMed ID: 36681189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma.
    Kim S; Bolatkan A; Kaneko S; Ikawa N; Asada K; Komatsu M; Hayami S; Ojima H; Abe N; Yamaue H; Hamamoto R
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31805626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPX4 inhibits apoptosis of thyroid cancer cells through regulating the FKBP8/Bcl-2 axis.
    Dang T; Yu J; Yu Y; Jiang J; Shi Y; Yu S; Peng C; Min X; Xiong Y; Long P; Zhou W; Dai D
    Cancer Biomark; 2024; 39(4):349-360. PubMed ID: 38250761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
    Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
    Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.
    Burg JM; Gonzalez JJ; Maksimchuk KR; McCafferty DG
    Biochemistry; 2016 Mar; 55(11):1652-62. PubMed ID: 26673564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
    Wu J; Chai H; Li F; Ren Q; Gu Y
    Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
    Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
    Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.